Ratings by Stifel (Ben Burnett)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/31/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 2/27/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2025 | Arcellx Inc. | ACLX | Maintain | Buy (Buy) |
|
Details | ||
| 1/24/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
21.30 (0.48) |
-97.75% | Details | |
| 6/3/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Kinnate Biopharma | KNTE | Maintain | Hold (N/A) |
|
Details | ||
| 2/22/2024 | Gracell Biotechnologies Inc | GRCL | Downgrade | Hold (Buy) |
10.25 (10.25) |
0% | Details | |
| 2/9/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
56.02 (58.70) |
4.78% | Details | |
| 10/19/2023 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
2.61 (10.25) |
292.72% | Details | |
| 10/19/2023 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
14.62 (3.04) |
-79.21% | Details | |
| 9/21/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Kinnate Biopharma | KNTE | Maintain | Hold (N/A) |
|
Details | ||
| 4/24/2023 | Ideaya Biosciences | IDYA | Upgrade | Buy (Hold) |
14.93 (36.26) |
142.87% | Details | |
| 4/21/2023 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
25.76 (86.22) |
234.7% | Details | |
| 4/18/2023 | Kinnate Biopharma | KNTE | Maintain | Hold (N/A) |
|
Details | ||
| 3/16/2023 | Kinnate Biopharma | KNTE | Maintain | Hold (N/A) |
|
Details | ||
| 3/14/2023 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
26.92 (87.33) |
224.41% | Details | |
| 3/7/2023 | Ideaya Biosciences | IDYA | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Kinnate Biopharma | KNTE | Downgrade | Hold (Buy) |
10.11 (2.65) |
-73.79% | Details | |
| 11/9/2022 | Ideaya Biosciences | IDYA | Maintain | Hold (N/A) |
|
Details | ||
| 8/15/2022 | Ideaya Biosciences | IDYA | Downgrade | Hold (Buy) |
15.65 (36.26) |
131.69% | Details | |
| 8/4/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 7/13/2022 | Revolution | RVMD | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/1/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | Kinnate Biopharma | KNTE | Maintain | Buy (Buy) |
|
Details | ||
| 5/10/2022 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/29/2022 | Kinnate Biopharma | KNTE | Maintain | Buy (Buy) |
|
Details | ||
| 3/15/2022 | Ideaya Biosciences | IDYA | Maintain | Buy (Buy) |
|
Details | ||
| 3/9/2022 | Ideaya Biosciences | IDYA | Upgrade | Buy (Hold) |
12.19 (36.26) |
197.46% | Details | |
| 3/1/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Revolution | RVMD | Upgrade | Buy (Hold) |
18.92 (47.50) |
151.06% | Details | |
| 2/16/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Kinnate Biopharma | KNTE | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 1/7/2022 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | Ideaya Biosciences | IDYA | New Coverage | Hold (N/A) |
27.02 (12.19) |
-54.89% | Details | |
| 9/23/2021 | Revolution | RVMD | New Coverage | Hold (N/A) |
32.05 (170.35) |
431.51% | Details | |
| 9/23/2021 | Repare Therapeutics | RPTX | New Coverage | Buy (N/A) |
28.79 (26.21) |
-8.96% | Details | |
| 9/23/2021 | Kinnate Biopharma | KNTE | New Coverage | Buy (N/A) |
22.45 (2.65) |
-88.2% | Details | |
| 9/23/2021 | Mirati Therapeutics | MRTX | New Coverage | Buy (N/A) |
167.09 (58.70) |
-64.87% | Details | |
| 6/23/2020 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 6/22/2020 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 3/5/2020 | CRISPR Therapeutics | CRSP | New Coverage | Hold (N/A) |
51.15 (54.16) |
5.88% | Details |
